Scanmed, a Warsaw, Poland-based healthcare company, acquired Ars Medical, another Polish cancer care treatment company.
The amount of the deal, supported by Abris Capital Partners, was not disclosed.
With the acquisition, Scanmed will become the largest independent healthcare provider in Poland. The deal will broaden Scanmed’s offer to accommodate the needs of its clients and will strengthen its position as a private in-patient healthcare provider. Additionally, the acquisition will enable synergies with existing Scanmed facilities and expand the company’s presence in north-west Poland.
Led by CEO Dr Zygmunt Malinowski, Ars Medical specialises in oncology, haematology, cardiology, internal medicine and palliative care, as well as general and specialist outpatient care. The company is a local players in cancer care treatment, diagnostic imaging and commercial procedures, and has a team of 400 doctors and nurses, including over 100 specialists in 48 therapeutic areas.
Led by CEO Andrzej Podlipski, Scanmed is a healthcare providers in Poland, offering a wide range of medical services within primary care, outpatient specialist consultations, diagnostics and inpatient/hospital treatment. Scanmed Group offers its patients an access to comprehensive therapeutic methods, technologically advanced and medical equipment and experienced specialists to facilitate their recovery. The group operates in more than 40 locations across Poland and runs the following medical facilities: two multi-specialist hospitals: St. Raphael in Krakow and Rudolf Weigl in Blachownia, 13 cardiac cath labs, three well-recognised inpatient clinics: Gastromed in Lublin, Sport-Klinika in Żory and Weiss Klinik in Chorzów.
Abris acquired Scanmed in 2020 with a plan to build a local healthcare champion by improving and growing the group’s service offering in key therapeutic areas including cardiology, oncology, orthopedics and ophthalmology, and expand its countrywide geographic coverage.